SARS-CoV-2 enzyme inhibitors among drugs screened for repurposing


Sumary of SARS-CoV-2 enzyme inhibitors among drugs screened for repurposing:

  • In the context of the coronavirus disease 2019 (COVID-19) pandemic, with over 3.5 million deaths and counting as of June 9, 2021, the development of effective antivirals remains essential..
  • This persistent need is largely due to the fact that most of the currently available vaccines target the spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which appears to constantly undergo rapid and critical mutations..
  • A new bioRxiv* preprint describes the identification of some promising pharmaceutical compounds that could be developed as antiviral drugs against COVID-19..
  • Blue Planet Studio / Background The SARS-CoV-2 genome encodes ten open reading frames (ORFs), the largest of which is ORF1ab..
  • These actions are important in regulating antiviral host innate immune responses and promoting successful infection by SARS-CoV-2..
  • Molecular docking studies on the top hits helped clarify how these compounds bound to the PLpro active site by different modes..
  • These findings indicate potential opportunities for repurposing these drugs to help in the ongoing fight to treat patients with severe COVID-19…

Want to know more click here go to source.

From -
Generic selectors
Exact matches only
Search in title
Search in content

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.